Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Facts & Figures
  3. #28

Facts & Figures · Review / Edit

Antepartum haemorrhage – RhD-negative women and anti-D prophylaxis

Record #28 · Edit the content, source and classification relationships.

PreviousNext
SQL status stored
Candidate visibility Not candidate-visible
Classifications 3
Related questions 9
Facts & Figures list

Facts & Figures #28 — Edit

Currently stored
stored

Status control does not offer the stored value. This record is stored as stored, but this legacy control only offers generated / needs_review / approved / retired. Saving this form will submit the selected value shown above (currently generated) and replace stored.

This is a known backend issue reported separately; it has not been changed in this visual redesign.

Source

Back to list

Classification Relationships — through Subtopic3

3 assigned
Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ Fetomaternal haemorrhage testing
Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ RhD-negative anti-D prophylaxis
Obstetrics and Gynaecology→ Clinical→ Delivery suite→ Haemorrhage→ Antepartum haemorrhage→ General→ Rhesus prophylaxis

Related Questions (9)

Matched through Subtopic3
SSBA Q65 generated
An RhD-negative woman at 31 weeks presents with a significant antepartum haemorrhage. She has no anti-D antibodies. Which investigation is specifically required to determine whether additional anti-D immunoglobulin is necessary?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBA Q76 generated
A non-sensitised RhD-negative woman at 30 weeks has recurrent episodes of antepartum haemorrhage. She received anti-D immunoglobulin following an earlier episode three weeks ago. She now presents with another significant bleed. Which statement is most appropriate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBA Q136 generated
An unsensitised RhD-negative woman at 34 weeks has a significant APH. A standard dose of anti-D immunoglobulin is given. Kleihauer testing subsequently demonstrates a fetomaternal haemorrhage exceeding that covered by the administered dose. What is the most appropriate next step?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBA Q166 generated
An unsensitised RhD-negative woman has recurrent APH at 29, 31 and 33 weeks. She received anti-D after the first episode. Following the third episode, a colleague argues that no further prophylactic assessment is necessary because all three bleeds probably arise from the same placental pathology. Which principle is most appropriate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
SSBA Q170 generated
An unsensitised RhD-negative woman at 33 weeks presents with painful APH and uterine tenderness. Ultrasound demonstrates no retroplacental collection. Kleihauer testing shows a significant fetomaternal haemorrhage. Which interpretation is most accurate?
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQ Q218 generated
Select the single most appropriate approach to rhesus prophylaxis.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQ Q230 generated
Select the single most appropriate investigation to determine whether additional anti-D immunoglobulin is required.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Rhesus prophylaxis
Open Question
EEMQ Q261 generated
Select the single most appropriate rhesus-management principle.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → RhD-negative anti-D prophylaxis
Open Question
EEMQ Q262 generated
Select the single most appropriate purpose of fetomaternal haemorrhage testing in this setting.
Delivery suite → Haemorrhage → Antepartum haemorrhage → General → Fetomaternal haemorrhage testing
Open Question